The global manual pipettes market was estimated at USD 4.23 billion in 2023, which is expected to reach USD 6.67 billion at a CAGR of 4.66% during 2023-2033.
Manual pipettes are instruments operated by hand and are used to conduct measurements with accuracy as well as dispense micro-doses of liquids. The manual pipettes industry spreads across pharmaceutical, biotechnological, clinical, and academic applications. Despite the availability in market of electronic pipettes, the manual pipettes industry continues to stay relevant due to a host of reasons. The most notable of these is the fact that electronic pipettes cost too much. Tastes and preferences also feature as a reason, since some people are used to the agency that operating manual pipettes allows them to exert. As an extension of this, another reason is that not all functionalities offered by electronic pipettes are seen as requirements whose satisfaction is actively being sought. In addition, electronic pipettes are also seen as too convoluted by some to use, while some find them to weight too much and others are bothered by the fact that they must not forget to charge their devices for smooth usage.
The manual pipettes market is thriving due to the primary push offered by the growing prevalence of pharmaceutical and biotechnology firms. Also, instruments enabling accurate measurements are being increasingly demanded in scientific settings. Additionally, the manual pipettes market is also driven by the rise in extent of research and development projects. The market is also pushed forward by the fact that electronic pipettes face a range of resistances in their adoption, allowing manual pipettes to continue being the candidate of choice.
However, constraints exist for the manual pipettes industry. A major constraint is the seemingly impending event of widespread adoption of electronic pipettes. Such a possibility is concerned with a behavioural shift which will plausibly take time, since preferences formed over a long period can be sticky and impose inertia. Hence, the popularity of manual pipettes will not be challenged overnight, but will arguably be constrained based on how well advances in technology translate into everyday laboratory work, and the extent of their adoption/readiness with which they are adopted. Within the context of academic research, manual pipettes face the constraints which bind a fast-paced research culture. A preference for automation over manual pipetting is reasoned on facts such as prevention of hand/elbow strain and risk of contamination while handling liquids. A more efficient workflow is highly sought for career-advancement by opting for methods that make results deemed worthy of publishing more probable.
Opportunities in the market arise from the continued reliance in many laboratory and clinical settings on manual pipettes. Manual pipettes are in many cases the only kind of available pipettes in countless laboratories, be it due to the expensive acquirement of electronic pipettes or an established culture of work. The professional staff responsible for handling labs in such cases also tends to either be unaware or only barely aware of the alternative of electronic pipettes, as a result of which, a lot of crucial everyday scientific processes being performed in labs and such strongly employ manual pipetting techniques using manual pipettes.
Several partnerships and acquisitions in the manual pipettes market have been directed in recent years, which would boost the overall manual pipettes market. Some of them are:
• In a press release dated 26 March 2024, ‘Eppendorf Group’ announced the 5-year renewal of a 10 years-long partnership with ‘LabCentral’, a well-known life sciences incubator. The former has been a partner since 2014 and a founding sponsor since 2019. The Eppendorf Group, which is a popular life science company, aims to gain from the strategic partnership by supplying a host of instruments, including pipettes, to be situated within LabCentral’s shared facilities.
• In a press release dated 21 November 2022, ‘Hamilton’, a pioneer in liquid handling solutions, announced its acquisition of the micro-dosing company, ‘BioFluidiX’. The acquisition formed part of Hamilton’s strategic foray into Freiburg, involving an expansion of its infrastructure in the German city. With a planned move into the FRIZ innovation centre, a facility on the premises of the University of Freiburg, Hamilton stands to gain from the closeness to the communities of students and scientists alike, driving innovation in the area.
The manual pipettes market is segmented based on type, application, and region.
Based on type, the market is bifurcated into single channel and multichannel pipettes.
Single channel pipettes, in general, are characterized by dispensation of liquids in micro-volumes up to 2500 microlitres. They are supplied as adjustable/fixed volume pipettes.
Multichannel pipettes enable increased output and reduced sample/production costs simultaneously. Currently, market variants exist that allow simultaneous pipetting of 8-12 samples. In this way, multichannel pipettes help run labs efficiently.
Based on application, the market is divided into laboratory, hospitals and clinics.
The laboratory market segment dominates the rest. The use of pipettes in labs tends to involve transferring liquids between containers in a swift and accurate manner. Lab technicians are also generally considerably more familiar with manual pipettes as opposed to electronic pipettes. Many factors are responsible for this: years of usage building familiarity with manual pipettes, level of control afforded by manual pipettes, lack of complexity relative to electronic pipettes, easier availability of manual variants due to lower cost of acquisition, and so on. Lastly, pipettes serve as a sanitised and disinfected instrument to aspirate, transport, and dispense fluids, further promising qualitative standards in laboratories.
Geographically, the manual pipettes market is present across regions such as North America, Europe, Asia-Pacific, and rest of the world.
North America forms the largest market in terms of revenue share. This is due to the rise in frequency of clinical trials in the region, which is facilitated by a buzzing pharmaceutical industry. Clinical trials have also grown in prevalence owing to collaborations between said pharmaceutical industry and academic institutes, government-affiliated or otherwise. A rising focus on research and development, hence, has fed the focus on clinical trials.
The manual pipette market has been outperforming the electronic pipette market in Europe until as recently as 2019, hence their wide usage in the region is apparent. Biotechnological companies claim a stronghold in the region, which along with the growing prevalence of clinical trials here as well, are factors that have positively affected the manual pipettes market in the region. The costs associated with acquiring electronic pipettes are expected to keep their demand on the bay for now at least, promising further scope for the manual pipettes market in Europe.
The increased focus on research and development paired with the regional boom in pharmaceutical and biotechnology industries drive the Asia-Pacific segment.
The manual pipettes market is characterized by competition in a state of flux. The market players are variegated, including established pioneers as well as zealous start-ups. The resulting competitive market atmosphere is intense, and accordingly drives innovative projects, product launches, and pricing strategies that help distinguish oneself from others. The scope of the market at any given moment is also a function of external factors such as altered regulations and dynamic consumer demands. Noted qualities of the market invite strategies such as collaborating with and acquiring companies not only to exploit the expansive nature of the market, but also to weather the challenging nature of it.
In recent years, the market has witnessed several developments as companies strive to expand their product portfolios, geographical reach, and market share. For instance:
• In a news report posted by ‘Gilson’, a U.S. based supplier of scientific services and products, the company announced that its Brazilian distributor, ‘SINAPSE’, will provide pipetting services from their calibration lab. The newly-established service centre will act as an efficient space for servicing of pipettes for Latin American laboratories.
• On 7 September 2022, a science news report on ‘Acura’ manual micropipettes manufactured by ‘Socorex ISBA’, a Swiss precision liquid dosing company, was posted detailing its product design. It is noted that the manual micropipette is particularly ergonomic and reduces risk of injury due to repetitive strain. This is especially notable since manual pipetting is generally considered to obstruct smooth conduction of long routine tests. Features such as reduced friction and smooth plunger activation are highlighted, along with low-pressure activation and easy tip ejection. Constraints such as restricted availability of types of pipette tips are countered by a shaft height adjustment system allowing for a range of tips securely fitting the nozzle, proving especially useful in labs. Macro-pipettes and multichannel pipettes are variants offered. Lastly, the report notes the cost-effective nature of sets on sale, allowing labs working under budget constraints to access premium pipette products.
The prominent players in this market are Brand, Capp, Corning Incorporated, Denville Scientific, Eppendorf AG, Gilson, Greiner Bio-One International, Hamilton Company, Integra Biosciences, Mettler-Toledo International, Nichiriyo Co., Sartorius, Socorex ISBA, and Thermo Fisher Scientific.
Manual Pipettes Market Scope:
Report Data | Manual Pipettes Market |
Manual Pipettes Market Forecast Value 2033 | 6.67Billion |
Manual Pipettes Market CAGR 2023 - 2033 | 4.66% |
Manual Pipettes Market Forecast Period | 2023 - 2033 |
Manual Pipettes Market Base Year | 2022 |
Regional Scope | North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Key Companies Profiled | Brand, Capp, Corning Incorporated, Denville Scientific, Eppendorf AG, Gilson, Greiner Bio-One International, Hamilton Company, Integra Biosciences, Mettler-Toledo International, Nichiriyo Co., Sartorius, Socorex ISBA, and Thermo Fisher Scientific.. |
Key Segments | By Type By Application By Region |
Report Coverage | Market Sizing, Market Forecasting, Market Dynamics, Market Trends, Market Development Analysis, Market Share Analysis, Regional Analysis, Competitive Positioning, Competitive Benchmarking, Competitive Landscape, Company Profiling, Regulation Analysis, etc. |
Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
Segmentation on the basis of any specific country or region
Any segment can be classified on the basis of application
Application segment can be further divided on the basis of companies
The companies profiled are not limited, we can incorporate additional companies of your choice
We can split the company market share on the basis of product, application and region
Report can be prepared for any specific country/region/segment
Customers can be added on the basis of regions and countries
We manage our resources 24/7 to identify issues and address them before they become problems
We are committed to providing reliable and highly accurate data with an excellent quality control system
6 Major regions and 40+ countries level analysis accomplished
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
Reports Published Per Year
Consulting Projects till date
Fortune 500 Clients
Analysts and Contract Consultants